Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02733419
What this trial is testing

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 84
Testing effectiveness (Phase 2)Study completedNCT00158509
What this trial is testing

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

Who this might be right for
Herpes GenitalisHIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 215
Large-scale testing (Phase 3)Study completedNCT01066962
What this trial is testing

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 800
Post-approval studies (Phase 4)Ended earlyNCT01417988
What this trial is testing

Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment

Who this might be right for
HIV InfectionTuberculosis
Prof JMA Lange 44
Early research (Phase 1)Study completedNCT02028403
What this trial is testing

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Ended earlyNCT00768989
What this trial is testing

Phase IIB Pilot of Atazanavir + Raltegravir

Who this might be right for
HIV
Bristol-Myers Squibb 167
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00641888
What this trial is testing

Impact of Antiretroviral Therapy on Cardiac Biomarkers

Who this might be right for
HIV Infections
University of California, Davis 40
Testing effectiveness (Phase 2)Ended earlyNCT01737359
What this trial is testing

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Who this might be right for
Human Immunodeficiency Virus Infection
RFS Pharma, LLC 2
Not applicableStudy completedNCT00002217
What this trial is testing

Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00445146
What this trial is testing

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

Who this might be right for
HIV Infections
Gilead Sciences 192
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Post-approval studies (Phase 4)Study completedNCT00335322
What this trial is testing

ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

Who this might be right for
Human Immunodeficiency Virus (HIV)
Kirby Institute 329
Testing effectiveness (Phase 2)Study completedNCT02397694
What this trial is testing

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 98
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Not applicableStudy completedNCT01456962
What this trial is testing

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

Who this might be right for
Women's HealthHIV InfectionGenital Diseases, Female
University of Colorado, Denver 36
Not applicableWithdrawnNCT03660722
What this trial is testing

Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects

Who this might be right for
HIV Positive
Centre Hospitalier Universitaire de Saint Etienne
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07209267
What this trial is testing

Baricitinib Curative Repression of HIV-1

Who this might be right for
HIV InfectionHIV
Emory University 35
Not applicableStudy completedNCT00067795
What this trial is testing

Evaluating Immune Function Tests in People With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation